MedicarePartD.guide

A non-government resource built from CMS public data

Fetzima on SilverScript Choice (S5601-036)

levomilnacipran hydrochloride

Covered, with prior authorization required.

Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.

$179.49
Patient pays / month, after deductible
$543.90
Patient pays / month, before the $615.00 deductible
$538.46
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

FETZIMA 80 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $543.90 for a month. Other covered strengths are listed below.

Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
FormTierPatient pays / monthLimits
FETZIMA 120 mg Capsule, Extended Release4$179.83PA · 30 per 30 days
FETZIMA 20 mg Capsule, Extended Release4$359.32PA · 60 per 30 days
FETZIMA 40 mg Capsule, Extended Release4$358.96PA · 60 per 30 days
FETZIMA 80 mg Capsule, Extended Release4$179.49PA · 30 per 30 days
FETZIMA Kit433%PA

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-036